Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.09	305.17	267.48
Graham Fair Price	-78.98	3915.76	18626.99
PEG	22625.50	3.87	-0.02
Price/Book	-3.87	3.92	4.08
Price/Cash Flow	-55.14	-31.53	70.29
Prices/Earnings	-2064.08	-369.95	-17.09
Price/Sales	-8.34	2.43	2.65
Price/FCF	-55.14	-31.53	70.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.75	0.26	0.24
Operating Margin	-36.65	0.01	-0.02
ROA	95.83	< 0.005	-0.01
ROE	-0.06	< 0.005	95.56
ROIC	< 0.005	< 0.005	63.80
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.19	< 0.005	8810.74
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.36	1.66	-50.56
EPS QOQ	-10.04	0.96	-90.48
FCF QOQ	-0.38	-3.14	-730.59
Revenue QOQ	-0.07	0.05	-37.13
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.04	73.05	-7.58
Days Sales Outstanding (DSO)	26.30	26.82	2.00
Inventory Turnover	1.14	1.23	8.20
Debt/Capitalization	0.66	0.71	7.98
Quick Ratio	0.60	0.82	36.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16074.10	16032.50	-0.26
Cash	11673.58	17636.28	51.08
Capex	-349.76	-349.51	0.07
Free Cash Flow	933.22	-1994.89	113.76
Revenue	24769.64	25911.04	4.61
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.36	16.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	86.58	108.77	25.63
Naive Interpretation	Member

06 - Financial Health · Weak

Rating